Search - tctmd.com

Displaying 581 - 600 of 699

Sort: Relevancy | Date

Presentation TCT 2013

Renal Denervation: Potential in Treating Heart Failure

Presenter: Erwin Blessing

October 28, 2013

Presentation TCT 2013

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

Presenter: Richard Heuser

October 28, 2013

Presentation TCT 2013

Renal Denervation: Ready for Primetime?

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

Non-Renal Targets for Sympathetic Modification

Presenter: Paul Sobotka

October 28, 2013

Presentation TCT 2013

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Presenter: Stephen Worthley

October 28, 2013

Presentation TCT 2013

Endovascular Interventions: Lower Extremity, Aorta, Renal and Carotid Disease

Presenter: Satya Reddy Atmakuri

October 28, 2013

Presentation TCT 2013

Strategies for Measuring Technical Success to Facilitate Ideal Patient Selection in Renal Denervation

Presenter: Paul Sobotka

October 27, 2013

Presentation TCT 2013

Renal Denervation for Glycemic Control and Obstructive Sleep Apnea: An Update

Presenter: Felix Mahfoud

October 27, 2013

Presentation TCT 2013

Ethanol Injection for Renal Denervation (Ablative Solutions)

Presenter: Tim Fischell

October 27, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Presentation TCT 2013

Selecting the Patient Most Likely to Benefit from Renal Artery Intervention

Presenter: Christopher White

October 27, 2013

Presentation TCT 2013

Renal Revascularization Data Review and Recommendations for Management

Presenter: Jeffrey Olin

October 27, 2013

Presentation TCT 2013

Renal Denervation for Congestive Heart Failure: Current Evidence and Ongoing Studies

Presenter: Justin Davies

October 27, 2013

Presentation TCT 2013

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Presenter: Felix Mahfoud

October 27, 2013

Presentation TCT 2013

Is Renal Denervation REALLY READY for Prime Time: A Critical Appraisal

Presenter: Darrel Francis

October 27, 2013

Presentation TCT 2013

How We Should Define "Responsiveness" to Renal Denervation Therapies

Presenter: Krishna Rocha-Singh

October 27, 2013

Presentation TCT 2013

FDA Perspectives: Clinical Trial Regulatory Pathway for Renal Denervation Devices

Presenter: Andrew Farb

October 27, 2013

Presentation TCT 2013

Electrophysiological Considerations for Renal Denervation: Implications for Arrhythmia Control

Presenter: Vivek Reddy

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Cordis Renal Denervation Approach

Presenter: Marc Sapoval

October 27, 2013

Advertisement

Renal Denervation: Potential in Treating Heart Failure

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

Renal Denervation: Ready for Primetime?

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Non-Renal Targets for Sympathetic Modification

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Endovascular Interventions: Lower Extremity, Aorta, Renal and Carotid Disease

Strategies for Measuring Technical Success to Facilitate Ideal Patient Selection in Renal Denervation

Renal Denervation for Glycemic Control and Obstructive Sleep Apnea: An Update

Ethanol Injection for Renal Denervation (Ablative Solutions)

The Spectrum of Current and Future Renal Denervation Clinical Trials

Selecting the Patient Most Likely to Benefit from Renal Artery Intervention

Renal Revascularization Data Review and Recommendations for Management

Renal Denervation for Congestive Heart Failure: Current Evidence and Ongoing Studies

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Is Renal Denervation REALLY READY for Prime Time: A Critical Appraisal

How We Should Define "Responsiveness" to Renal Denervation Therapies

FDA Perspectives: Clinical Trial Regulatory Pathway for Renal Denervation Devices

Electrophysiological Considerations for Renal Denervation: Implications for Arrhythmia Control

Device and Clinical Trial Update: Cordis Renal Denervation Approach

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content